Radiolabeling of magnetic targeted carriers (MTC) with indium-111

被引:10
|
作者
Häfeli, UO
Yu, JF
Farudi, F
Li, YH
Tapolsky, G
机构
[1] Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA
[2] Chinese Acad Sci, Shanghai Inst Nucl Res, Shanghai 201800, Peoples R China
[3] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
[4] FeRx Inc, Aurora, CO 80010 USA
关键词
magnetic targeting; microspheres; radiolabeling; indium-111; yttrium-90; imaging;
D O I
10.1016/S0969-8051(03)00077-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Magnetic targeted carriers (MTC) are magnetically susceptible microparticles that can be physically targeted to a specific site. MTC were radiolabeled with In-111 using three different methods. Reaction parameters were investigated in order to optimize the final properties of the labeled MTC. The reaction parameters studied were chelation agent, chelation time, temperature, radiolabeling time, solvent, and molar ratios. A 97.7 +/- 0.9% binding efficiency and plasma stability of 92.6 +/- 0.1% over 7 days were achieved when 2-p-aminobenzyl-1,4,7, 10-tetraazacyclododecane-1,4,7,10-tetra-acetic acid (ABz-DOTA) was used as the chelating agent. A preliminary animal biodistribution study confirmed the binding stability. The labeling of the MTC with the diagnostic isotope In-111 was undertaken to allow for quantitative imaging and dosimetry prior to therapy with Y-90 radiolabeled MTC. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 50 条
  • [1] Pre-targeted radioimmunotherapy: Validation of methods for radiolabeling of DOTA-biotin with Indium-111 and Yttrium-90
    Velez, J.
    Thostenson, C.
    Hamlin, D.
    Wilbur, D. Scott
    Pagel, John
    Gopal, Ajay
    Press, Oliver
    Rajendran, Joseph
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [2] Comparison of Indium-111 pentetreotide SPECT, Indium-111 pentetreotide planar and magnetic resonance imaging in detecting hepatic metastasis in patients with neuroendocrine tumors
    Ih, Grace
    Zalom, Martina
    Waxman, Alan
    Su, Andrew
    Craig, Natasha
    Wachsman, Ashley
    D'Agnolo, Alessandro
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [3] Indium-111 DTPA-heparin: Radiolabeling, pharmacokinetics, and biodistribution following intravenous administration in rat and rabbit
    Bunting, RW
    Wilkinson, RA
    Callahan, RJ
    Strauss, HW
    Fischman, AJ
    THROMBOSIS RESEARCH, 1998, 89 (01) : 23 - 30
  • [4] Targeted radiopeptide therapy: High dose indium-111 octreotide for neuroendocrine tumours
    Caplin, ME
    Burroughs, AK
    Miolcarek, W
    Hilson, AJW
    Jones, AL
    Wood, EJ
    Buscombe, JR
    GUT, 1998, 42 : A51 - A51
  • [5] INDIUM-111 LABELED CANINE PLATELETS
    WILKINSON, AR
    HAWKER, RJ
    HAWKER, LM
    THROMBOSIS RESEARCH, 1978, 13 (02) : 175 - 182
  • [6] Radiolabeling, selection and evaluation of indium-111 labeled anti-mesothelins in human mesothelin-expressing xenografts
    Hsu, W.
    Cheng, K.
    Chang, Y.
    Ho, C.
    Yu, C.
    Yang, S.
    Hsu, H.
    Yang, C.
    Chang, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S681 - S681
  • [7] Targeted radiopeptide therapy: High dose indium-111 octreotide for neuroendocrine tumours.
    Caplin, ME
    Burroughs, AK
    Miolcarek, W
    Hilson, AJW
    Jones, AL
    Wood, EJ
    Buscombe, JR
    GASTROENTEROLOGY, 1998, 114 (04) : A574 - A574
  • [8] INDIUM-111 LABELED GAMMA-GLOBULIN
    PRITCHAR.JH
    TUBIS, M
    BLAHD, WH
    ENDOW, JS
    MACDONAL.NS
    JOURNAL OF NUCLEAR MEDICINE, 1974, 15 (06) : 526 - 526
  • [9] INDIUM-111 LABELED LEUKOCYTES FOR LOCALIZATION OF ABSCESSES
    THAKUR, ML
    COLEMAN, RE
    WELCH, MJ
    JOURNAL OF NUCLEAR MEDICINE, 1976, 17 (06) : 560 - 561
  • [10] Indium-111 octreotide uptake in the surgical scar
    Degirmenci, B
    Bekis, R
    Sen, M
    Durak, H
    Derebek, E
    NUKLEARMEDIZIN, 1999, 38 (07) : 306 - 308